Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Net Cash Flow (2018 - 2019)

Historic Net Cash Flow for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to -$858000.0.

  • DiaMedica Therapeutics' Net Cash Flow fell 10663.83% to -$858000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was -$12.9 million, marking a year-over-year decrease of 18364.58%. This contributed to the annual value of -$1.5 million for FY2024, which is 73351.35% down from last year.
  • According to the latest figures from Q4 2019, DiaMedica Therapeutics' Net Cash Flow is -$858000.0, which was down 10663.83% from $1.8 million recorded in Q3 2019.
  • Over the past 5 years, DiaMedica Therapeutics' Net Cash Flow peaked at $12.9 million during Q4 2018, and registered a low of -$14.1 million during Q1 2019.